News

Join our newsletter

Sign up to read about our latest portfolio updates, fund news and industry insights.

Thanks for subscribing to our newsletter
Oops! Something went wrong

Latest news

Portfolio
//
Clarity Movement
//
July 15, 2019

Bloomberg funds one of the densest air monitoring networks with Clarity in Paris, France | by Clarity Team | Clarity Movement | Medium

Clarity is launching one of our most exciting projects to date: a 150-sensor network in Paris with Bloomberg Philanthropies and the City of Paris to better understand air quality within and around…

Portfolio
//
BioAmp Diagnostics
//
April 23, 2019

Illumina Accelerator Invests in Four New Startups | GenomeWeb

The four startups will have access to capital, business coaching, office space, and Illumina sequencing expertise over a six-month period.

Portfolio
//
ImpriMed
//
April 12, 2019

ImpriMed Raises $4M for Customized Cancer Treatments for Dogs

Precision medicine lowers the risks of treating lymphoma in dogs and eventually humans...

Portfolio
//
YourChoice Therapeutics
//
March 14, 2019

YourChoice Therapeutics is developing unisex, non-hormonal birth control – TechCrunch

Portfolio
//
GenEdit
//
February 16, 2019

Biotechnology Company GenEdit Raises $8,5M In A New Funding Round Led By DCVC And Sequoia Capital - Tech Company News

GenEdit, Inc. is biotechnology company focused on the development of novel, non-viral, nanoparticle-based delivery technologies...

Portfolio
//
Clarity Movement
//
October 1, 2018

Low-cost air quality sensors could be coming to Oakland residents | by Clarity Team | Clarity Movement | Medium

On a sunny day a week ago, representatives from government agencies, universities, industry and environmental nonprofits gathered at the Oakland Convention Center to talk about low-cost air quality…

Portfolio
//
//
August 8, 2018

Gastrointestinal Gene Therapy Biotech DNAlite Therapeutics Raises $1.5M in Seed Funding | Business Wire

DNAlite Therapeutics, Inc., an early stage preclinical therapeutic company has raised $1.5 million in a seed-stage financing. DNAlite was founded by U

Portfolio
//
GenEdit
//
October 5, 2017

Gold nanoparticles effectively deliver CRISPR to mouse models of DMD | Fierce Biotech

CRISPR-Cas9 has emerged in recent years as a promising weapon against genetic disease.